Estrella Immunopharma Names Cynthia Pussinen CEO and Board Chair

Bitget2026/10/29 21:40

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Estrella Immunopharma appointed Cynthia Pussinen CEO, Class I director and board chair, effective October 25, 2026.
Pussinen served as managing director, biotech investments, at Sorbie Bornholm from March to October 2026, previously leading Sernova as CEO.
Cheng Liu moved from CEO to chief scientific officer, effective October 25, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Estrella Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-113912), on October 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Estrella Immunopharma Names Cynthia Pussinen CEO and Board Chair

You may also like

Crypto prices